Literature DB >> 22173088

Comments on Mougey et al. (2009): Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics 19: 129-138.

Xiaoyan Chu, George Philip, Raymond Evers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22173088     DOI： 10.1097/FPC.0b013e32834e9e35

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  5 in total

1.  Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator.

Authors:  Yongkang Chen; Xiaohuan Wang; Huichun Shi; Peng Zou
Journal:  Viruses       Date:  2022-04-21       Impact factor: 5.818

Review 2.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

3.  Case Study 5: Predicting the Drug Interaction Potential for Inhibition of CYP2C8 by Montelukast.

Authors:  Ken Korzekwa
Journal:  Methods Mol Biol       Date:  2021

4.  Montelukast Disposition: No Indication of Transporter-Mediated Uptake in OATP2B1 and OATP1B1 Expressing HEK293 Cells.

Authors:  Marie Brännström; Pär Nordell; Britta Bonn; Andrew M Davis; Anna-Pia Palmgren; Constanze Hilgendorf; Katarina Rubin; Ken Grime
Journal:  Pharmaceutics       Date:  2015-12-15       Impact factor: 6.321

5.  Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.

Authors:  Päivi Hirvensalo; Aleksi Tornio; Mikko Neuvonen; Tuija Tapaninen; Maria Paile-Hyvärinen; Vesa Kärjä; Ville T Männistö; Jussi Pihlajamäki; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacol Ther       Date:  2017-11-06       Impact factor: 6.875
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.